Since STAT3 is known to directly regulate ICAM-1 expression in various cancer types, chromosome immunocompatibility (CHIP) assay was performed to investigate this role of STAT3 in CRC [21–23]. This evidence concerns the gene ICAM1 and colorectal carcinoma.